Editas Medicine, Inc. financial data

Symbol
EDIT on Nasdaq
Location
11 Hurley St., Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314 % -27.9%
Debt-to-equity 344 % +501%
Return On Equity -349 % -335%
Return On Assets -78.6 % -54.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97.6M shares +18.3%
Common Stock, Shares, Outstanding 93.3M shares +13%
Entity Public Float 384M USD -42.8%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 90.1M shares +9.22%
Weighted Average Number of Shares Outstanding, Diluted 90.1M shares +9.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 46.4M USD -24.9%
Research and Development Expense 111M USD -49.5%
General and Administrative Expense 54.9M USD -21.7%
Operating Income (Loss) -199M USD +13%
Nonoperating Income (Expense) -988K USD -106%
Net Income (Loss) Attributable to Parent -200M USD +5.1%
Earnings Per Share, Basic -2 USD/shares +5.93%
Earnings Per Share, Diluted -2 USD/shares +5.93%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 166M USD +72.9%
Marketable Securities, Current 0 USD -100%
Assets, Current 177M USD -34.8%
Property, Plant and Equipment, Net 4.29M USD -72.2%
Operating Lease, Right-of-Use Asset 17.6M USD -50.8%
Other Assets, Noncurrent 2.99M USD -43.4%
Assets 202M USD -38.4%
Accounts Payable, Current 3.16M USD -74.7%
Employee-related Liabilities, Current 6.16M USD -48.4%
Accrued Liabilities, Current 47.5M USD +65.1%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 61.8M USD -14.6%
Contract with Customer, Liability, Noncurrent 54.2M USD 0%
Operating Lease, Liability, Noncurrent 13.6M USD -38.6%
Other Liabilities, Noncurrent 4.69M USD +42.9%
Liabilities 188M USD +23.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -1.62B USD -14%
Stockholders' Equity Attributable to Parent 13.5M USD -92.3%
Liabilities and Equity 202M USD -38.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -47.8M USD +4.16%
Net Cash Provided by (Used in) Financing Activities -1.44M USD -848%
Net Cash Provided by (Used in) Investing Activities 56.4M USD
Common Stock, Shares Authorized 390M shares +100%
Common Stock, Shares, Issued 93.3M shares +13%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.15M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 168M USD +68.8%
Deferred Tax Assets, Valuation Allowance 389M USD +18.4%
Deferred Tax Assets, Gross 397M USD +17.7%
Operating Lease, Liability 35M USD -4.12%
Depreciation 1.92M USD +36.1%
Payments to Acquire Property, Plant, and Equipment 114K USD -93.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -200M USD +3.95%
Lessee, Operating Lease, Liability, to be Paid 39.9M USD -8.06%
Property, Plant and Equipment, Gross 31.8M USD -30.7%
Operating Lease, Liability, Current 6.09M USD -62.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.73M USD +15.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.1M USD +15.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.92M USD -28.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.08M USD -0.81%
Deferred Tax Assets, Operating Loss Carryforwards 171M USD +11.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 15.7M USD +14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6M USD -15.2%
Operating Lease, Payments 5.41M USD +40.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 8.49M USD -7.62%
Share-based Payment Arrangement, Expense 11.9M USD -47.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%